This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
MGC Pharmaceuticals Gestione
Gestione criteri di controllo 4/4
MGC Pharmaceuticals' CEO is Roby Zomer, appointed in Feb 2016, has a tenure of 7.75 years. total yearly compensation is A$354.02K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.76% of the company’s shares, worth A$18.77K. The average tenure of the management team and the board of directors is 2.8 years and 6.3 years respectively.
Informazioni chiave
Roby Zomer
Amministratore delegato
AU$354.0k
Compenso totale
| Percentuale dello stipendio del CEO | 100.0% |
| Mandato del CEO | 7.8yrs |
| Proprietà del CEO | 0.8% |
| Durata media del management | 2.8yrs |
| Durata media del Consiglio di amministrazione | 6.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2023 | AU$354k | AU$354k | -AU$21m |
| Mar 31 2023 | n/a | n/a | -AU$22m |
| Dec 31 2022 | n/a | n/a | -AU$23m |
| Sep 30 2022 | n/a | n/a | -AU$22m |
| Jun 30 2022 | AU$629k | AU$422k | -AU$20m |
| Mar 31 2022 | n/a | n/a | -AU$19m |
| Dec 31 2021 | n/a | n/a | -AU$18m |
| Sep 30 2021 | n/a | n/a | -AU$17m |
| Jun 30 2021 | AU$481k | AU$281k | -AU$16m |
| Dec 31 2020 | n/a | n/a | -AU$13m |
| Sep 30 2020 | n/a | n/a | -AU$16m |
| Jun 30 2020 | AU$440k | AU$290k | -AU$19m |
| Dec 31 2019 | n/a | n/a | -AU$18m |
| Sep 30 2019 | n/a | n/a | -AU$14m |
| Jun 30 2019 | AU$495k | AU$330k | -AU$11m |
| Dec 31 2018 | n/a | n/a | -AU$7m |
| Sep 30 2018 | n/a | n/a | -AU$7m |
| Jun 30 2018 | AU$498k | AU$334k | -AU$8m |
| Mar 31 2018 | n/a | n/a | -AU$10m |
| Dec 31 2017 | n/a | n/a | -AU$12m |
| Sep 30 2017 | n/a | n/a | -AU$10m |
| Jun 30 2017 | AU$783k | AU$233k | -AU$8m |
Compensazione vs Mercato: Roby's total compensation ($USD227.27K) is about average for companies of similar size in the Australian market ($USD295.83K).
Compensazione vs guadagni: Roby's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Roby Zomer (43 yo)
7.8yrs
Mandato
AU$354,018
Compensazione
Mr. Roby Reuven Zomer is a Co-Founder of MGC Pharmaceuticals Limited and served as its Interim Chief Financial Officer since April 2022 until April 2022. Mr. Zomer has been Managing Director since May 2018...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 7.8yrs | AU$354.02k | 0.76% A$ 18.8k | |
| Chief Accounting Officer | less than a year | Nessun dato | Nessun dato | |
| Deputy CEO & COO | 1.1yrs | Nessun dato | 0.39% A$ 9.5k | |
| Global Chief Sales Officer | 2.8yrs | Nessun dato | Nessun dato | |
| Chief Pharmaceutical Development Officer | no data | Nessun dato | Nessun dato | |
| Head of the Quality Assurance Department | 3.2yrs | Nessun dato | Nessun dato | |
| Chief Medical Officer | no data | Nessun dato | Nessun dato | |
| Deputy CEO | no data | Nessun dato | Nessun dato | |
| Chief Information Security Officer | no data | Nessun dato | Nessun dato | |
| Chief Commercial Officer | 1.3yrs | Nessun dato | Nessun dato | |
| Chief Manufacturing & Supply Chain Officer | no data | Nessun dato | Nessun dato | |
| Chief Executive Officer of MGC Derma | 5yrs | Nessun dato | Nessun dato |
2.8yrs
Durata media
Gestione esperta: MXCDA's management team is considered experienced (2.8 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 7.8yrs | AU$354.02k | 0.76% A$ 18.8k | |
| Non-Executive Chairman & Senior Independent Director | 4.7yrs | AU$30.59k | 0.045% A$ 1.1k | |
| Chairman of Strategic Advisory Board & Independent Non-Executive Director | 7.8yrs | AU$44.00k | 0.11% A$ 2.8k | |
| Member of Strategic Advisory Board | 7.3yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Member of Medical Advisory Board | 5.3yrs | Nessun dato | Nessun dato |
6.3yrs
Durata media
Consiglio di amministrazione esperto: MXCDA's board of directors are considered experienced (6.3 years average tenure).